Journal article
Very Early Changes in Quality of Life After Transcatheter Aortic Valve Replacement: Results From the 3M TAVR Trial
Abstract
BACKGROUND: Patients with severe, symptomatic aortic stenosis derive substantial 30-day quality of life (QOL) benefit from transcatheter aortic valve replacement (TAVR). Whether the QOL benefit of TAVR emerges earlier is unknown. We used data from the Multimodality, Multidisciplinary but Minimalist (3M) TAVR study to assess early changes in QOL after transfemoral (TF) TAVR.
METHODS: Health status was assessed at baseline, 2-weeks, 30-days, and …
Authors
Lauck SB; Arnold SV; Borregaard B; Sathananthan J; Humphries KH; Baron SJ; Wijeysundera HC; Asgar A; Welsh R; Velianou JL
Journal
Cardiovascular Revascularization Medicine, Vol. 21, No. 12, pp. 1573–1578
Publisher
Elsevier
Publication Date
December 2020
DOI
10.1016/j.carrev.2020.05.044
ISSN
1553-8389